GIARRATANO, TOMMASO

GIARRATANO, TOMMASO  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Use of scalp-cooling device to prevent alopecia for breast cancer patients receiving chemotherapy: a single-Institution prospective study 2017 Giarratano, TGuarneri, VGrosso, DMioranza, EVernaci, GConte, P + ANNALS OF ONCOLOGY - Abstract Book of the 19th National Congress of Medical Oncology 27–29 October 2017, Rome, Italy
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer 2017 Dieci, Maria VittoriaGuarneri, ValentinaGIARRATANO, TOMMASOMION, MARTATORTORA, GIAMPAOLODE ROSSI, COSTANZAGRIGUOLO, GAIAORVIETO, ENRICODel Bianco, PaolaDe Salvo, Gian LucaConte, Pierfranco + THE ONCOLOGIST - -
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study 2019 Giarratano T.Frezzini S.Giorgi C. A.Mioranza E.Miglietta F.Griguolo G.Tasca G.Di Liso E.Vernaci G.Menichetti A.Mantiero M.Grosso D.Guarneri V.Dieci M. V. + THE BREAST JOURNAL - -
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 2019 Dieci M. V.TSVETKOVA, VASSILENAGriguolo G.Miglietta F.MANTIERO, MARACumerlato E.Giorgi C. A.Giarratano T.FAGGIONI, GIULIA MARTINAVernaci G.Menichetti A.MIORANZA, ELEONORAFREZZINI, SIMONAOrvieto E.Guarneri V. + FRONTIERS IN ONCOLOGY - -
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 2020 Miglietta F.Dieci M. V.Tsvetkova V.Griguolo G.Vernaci G.Menichetti A.Faggioni G.Giarratano T.Mioranza E.Genovesi E.Cumerlato E.Bottosso M.Conte P.Guarneri V. + THE ONCOLOGIST - -
Erbb2 mrna expression and response to ado-trastuzumab emtansine (T-dm1) in her2-positive breast cancer 2020 Griguolo G.Tsvetkova V.Giarratano T.Dieci M. V.Conte P.Guarneri V. + CANCERS - -
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 2020 Di Liso, ElisabettaBottosso, MicheleTsvetkova, VassilenaDieci, Maria VittoriaMiglietta, FedericaTasca, GiuliaGiorgi, Carlo AlbertoGiarratano, TommasoMioranza, EleonoraDei Tos, Angelo PaoloConte, PierFrancoGuarneri, Valentina + ESMO OPEN - -
Evolution of HER2-low expression from primary to recurrent breast cancer 2021 Miglietta F.Griguolo G.Bottosso M.Giarratano T.Fassan M.Cacciatore M.Genovesi E.De Bartolo D.Vernaci G.Amato O.Conte P. F.Guarneri V.Dieci M. V. + NPJ BREAST CANCER - -
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 2022 Federica MigliettaGaia GriguoloMichele BottossoTommaso GiarratanoMatteo FassanMatilde CacciatoreElisa GenovesiDebora De BartoloGrazia VernaciOttavia AmatoFrancesca PorraPierFranco ConteValentina GuarneriMaria Vittoria Dieci + NPJ BREAST CANCER - -